Expertise in
46
conditions

Dr. Joel M. Charrow

Medical Genetics | Pediatrics
Lurie Children's Medical Group Inc.
225 E Chicago Ave, 
Chicago, IL 
Expertise in
46
conditions
Lurie Children's Medical Group Inc.
225 E Chicago Ave, 
Chicago, IL 

Overview

Joel Charrow is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Chicago, Illinois.

Dr. Charrow is highly rated in 46 conditions, according to our data. His clinical expertise encompasses Gaucher Disease Type 1, Gaucher Disease, Achondroplasia, Isovaleric Acidemia, and Splenectomy.

He is actively involved in clinical research, co-authoring 76 peer reviewed articles and participating in 5 clinical trials.

Specialties

Medical Genetics
Pediatrics

Licenses

Clinical Biochemical Genetics in IL

Hospital Affiliations

Ann & Robert H Lurie Childrens Hospital Of Chicago

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

LURIE CHILDREN'S MEDICAL GROUP INC.
225 E Chicago Ave, Chicago, IL 60611

Additional Areas of Focus

Dr. Charrow has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
Enrollment Status: Completed
Publish Date: August 21, 2026
Intervention Type: Drug
Study Drug: PEG-Zilarginase
Study Phase: Phase 3
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Drug
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Biological
Study Drugs: PRX-102 (Pegunigalsidase Alfa), Agalsidase Beta
Study Phase: Phase 3
An Open-label, Multicenter, Single-arm, Phase 4 Study of the Effect of Treatment With Velaglucerase Alfa on Bone-related Pathology in Treatment-naïve Patients With Type 1 Gaucher Disease
An Open-label, Multicenter, Single-arm, Phase 4 Study of the Effect of Treatment With Velaglucerase Alfa on Bone-related Pathology in Treatment-naïve Patients With Type 1 Gaucher Disease
Enrollment Status: Completed
Publish Date: February 01, 2022
Intervention Type: Dietary supplement, Drug
Study Phase: Phase 4
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

76 Total Publications

Clinical Experience With Eliglustat in Children With Gaucher Disease Type 1.
Clinical Experience With Eliglustat in Children With Gaucher Disease Type 1.
Journal: American journal of medical genetics. Part A
Published: April 27, 2026
Similar Doctors
Expertise in
23
conditions
Dr. Barbara K. Burton
Medical Genetics | Pediatrics
Expertise in
23
conditions
Dr. Barbara K. Burton
Medical Genetics | Pediatrics
Referral may be required
2300 Childrens Plaza, 
Chicago, IL 
 (2.4 miles away)
773-880-4462
Languages Spoken:
English
See accepted insurances

Barbara Burton is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Chicago, Illinois. Dr. Burton is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Phenylketonuria (PKU), Mucopolysaccharidoses (MPS), and Cholesteryl Ester Storage Disease.

Expertise in
172
conditions
Dr. Carlos E. Prada
Medical Genetics | Pediatrics
Expertise in
172
conditions
Dr. Carlos E. Prada
Medical Genetics | Pediatrics
Referral may be required

Lurie Children's Medical Group Inc.

225 E Chicago Ave, 
Chicago, IL 
 (0.1 miles away)
312-227-6415
Languages Spoken:
English
See accepted insurances

Carlos Prada is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Chicago, Illinois. Dr. Prada is highly rated in 172 conditions, according to our data. His clinical expertise encompasses RASopathies, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, and Smith-Kingsmore Syndrome.

Expertise in
21
conditions
Dr. Nitasha Sarswat
Cardiology | Medical Genetics | Transplant Surgery
Expertise in
21
conditions
Dr. Nitasha Sarswat
Cardiology | Medical Genetics | Transplant Surgery
Referral may be required
Before you request

Endeavor Health Medical Group

1000 Central St., Suite 730, 
Evanston, IL 
 (12.0 miles away)
847-503-8100
Languages Spoken:
English, Hindi, Punjabi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Nitasha Sarswat is a Cardiologist and a Medical Genetics provider practicing medicine in Evanston, Illinois. Dr. Sarswat is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Cardiac Amyloidosis, Heart Failure, Primary Amyloidosis, Lung Transplant, and Heart Transplant. Dr. Sarswat is board certified in American Board Of Internal Medicine. Dr. Sarswat is currently accepting new patients.

Frequently Asked Questions about Dr. Joel M. Charrow

How do I make an appointment with Dr. Joel M. Charrow?

You can book an appointment with Dr. Joel M. Charrow by calling their office at 312-227-6415. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joel M. Charrow a top-rated expert for Gaucher Disease Type 1?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joel M. Charrow is classified as an Elite expert for Gaucher Disease Type 1, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joel M. Charrow specialize in?

While Dr. Joel M. Charrow is a Medical Genetics, they have specific expertise in Gaucher Disease Type 1, Gaucher Disease, and Achondroplasia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Medical Genetics.

Does Dr. Joel M. Charrow participate in research or clinical trials?

Yes. Dr. Joel M. Charrow has published 76 articles and abstracts on conditions like Gaucher Disease Type 1. You can view a list of Dr. Joel M. Charrow's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joel M. Charrow accept my insurance?

Dr. Joel M. Charrow accepts most major insurance plans, including Aetna and Humana. We recommend calling the office directly at 312-227-6415 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Charrow's expertise for a condition
ConditionClose
View All 13 Distinguished Conditions
View All 30 Advanced Conditions
View All 127 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile